Zimmer Biomet Holdings Inc represents a strong commitment to improving the quality of life for patients worldwide. With a focus on innovative medical solutions, Zimmer Biomet strives to provide effective and reliable orthopedic products and services. The company emphasizes integrity, collaboration, and excellence in everything it does, and aims to be a trusted partner for healthcare professionals. Zimmer Biomet's corporate philosophy revolves around delivering personalized treatment options, enhancing patient outcomes, and promoting sustainable healthcare solutions. By consistently pushing boundaries and investing in research and development, Zimmer Biomet aims to revolutionize orthopedic care and improve the lives of people around the globe.

Zimmer Biomet Holdings Inc is primarily present in various countries and regions around the world. Some of the key markets where this company operates include the United States, Europe, Asia-Pacific, and Latin America. With a strong global presence, Zimmer Biomet Holdings Inc has established itself as a leading player in the medical device industry. Its presence in multiple countries and regions allows the company to serve a diverse range of customers and cater to the healthcare needs of patients worldwide.

Zimmer Biomet Holdings Inc, a leading medical device company, has achieved significant milestones throughout its history. Firstly, the company's merger in 2015 between Zimmer Holdings and Biomet Inc increased its market presence and product portfolio. Zimmer Biomet has also introduced innovative products such as the Persona® Knee System, which offers personalized knee replacement options. Moreover, the company's ongoing commitment to research and development has led to advancements in surgical robotics and orthopedic implants. With its strong emphasis on patient outcomes, Zimmer Biomet has gained recognition for its quality systems and regulatory compliance. As a result, the company continues to establish itself as a trusted leader in the global healthcare industry.

Zimmer Biomet Holdings Inc, a leading global medical device company, has a rich history and background. It was formed in June 2015 through the merger of Zimmer Holdings and Biomet Inc. With a heritage dating back to 1927, Zimmer Biomet has been at the forefront of developing innovative solutions for orthopedic and musculoskeletal healthcare. The company focuses on providing products and services that enhance patients' quality of life, including joint reconstruction, spine and dental implants, sports medicine, and surgical technologies. Zimmer Biomet is committed to advancing medical science, improving patient care, and addressing the evolving needs of the healthcare industry.

Some of the main competitors of Zimmer Biomet Holdings Inc in the market include Johnson & Johnson, Stryker Corporation, and Medtronic plc.

Zimmer Biomet Holdings Inc is primarily active in the medical device industry. With a strong focus on orthopedic and musculoskeletal healthcare, Zimmer Biomet specializes in designing, manufacturing, and marketing a wide range of innovative and technologically advanced surgical products and solutions. The company's offerings include joint replacement systems, surgical implants, robotics-assisted technology, trauma products, and dental prosthetics. Zimmer Biomet has expertise in serving patients, healthcare professionals, and hospitals worldwide, aiming to improve patients' quality of life through its diverse portfolio of products and commitment to advancing healthcare technologies.

The business model of Zimmer Biomet Holdings Inc is focused on the research, development, and manufacturing of medical devices and orthopedic solutions. As a global leader in musculoskeletal healthcare, Zimmer Biomet provides innovative products and technologies for joint replacement, spine and trauma operations, dental implants, and sports medicine. The company collaborates with healthcare professionals to improve patient outcomes and enhance quality of life. Zimmer Biomet operates through three key segments: Orthopaedics, Dental, and Spine & CMF (Craniomaxillofacial). By consistently delivering advanced medical solutions, Zimmer Biomet aims to address the evolving healthcare needs of patients worldwide.

The Zimmer Biomet Holdings P/E ratio is 13.26.

The Zimmer Biomet Holdings P/S ratio is 2.82.

The AlleAktien quality score for Zimmer Biomet Holdings is 3/10.

The expected Zimmer Biomet Holdings revenue is 7.81 B USD.

The expected Zimmer Biomet Holdings profit is 1.66 B USD.

Zimmer Biomet Holdings Inc is a global leader in the medical device industry. The company offers a wide range of solutions for orthopedics, traumatology, spinal and dental surgery. Zimmer Biomet's orthopedic division produces a variety of products for use in knee, hip, shoulder, hand, elbow, and foot surgery. These products range from artificial joints and implants to surgical instruments and biological materials. Zimmer Biomet's traumatology division offers a wide range of products for the treatment of bone fractures, including fixation materials and devices for soft tissue reconstruction. Zimmer Biomet's spinal division focuses on the treatment of spine disorders, including herniated discs and spinal canal diseases. These products include spinal fusion systems and devices for minimally invasive spinal surgery. Zimmer Biomet's dental surgery division offers a wide range of implants, instruments, and materials for tooth and jaw reconstruction and rehabilitation. The business model of Zimmer Biomet aims to provide hospitals, clinics, and doctors with a comprehensive range of solutions for orthopedic, traumatology, spinal, and dental surgery applications. The company operates its business in over 100 countries worldwide and is committed to meeting the needs of its customers by investing continuously in research and development. Zimmer Biomet pursues a two-brand strategy with the Zimmer and Biomet brands. The company leverages its size and expertise to develop innovative products and services for its customers while also building a strong brand presence. The company has a strong global presence and is able to operate in all major markets. Zimmer Biomet focuses on offering innovative solutions to complex medical problems while providing a high level of customer service and training support. Overall, Zimmer Biomet relies on its reputation and industry knowledge to understand the needs of its customers and provide tailored solutions. The company continues to strive to expand its leadership position in the medical device industry and explore new opportunities for growth and expansion.

Zimmer Biomet Holdings pays a dividend of 0.96 USD distributed over 4 payouts per year.

Zimmer Biomet Holdings pays out a dividend 4 times a year.

The ISIN of Zimmer Biomet Holdings is US98956P1021.

The WKN of Zimmer Biomet Holdings is 753718.

The ticker of Zimmer Biomet Holdings is ZBH.

Over the past 12 months, Zimmer Biomet Holdings paid a dividend of 0.96 USD . This corresponds to a dividend yield of about 0.92 %. For the coming 12 months, Zimmer Biomet Holdings is expected to pay a dividend of 0.97 USD.

The current dividend yield of Zimmer Biomet Holdings is 0.92 %.

Zimmer Biomet Holdings pays a quarterly dividend. This is distributed in the months of January, April, July, October.

Zimmer Biomet Holdings paid dividends every year for the past 18 years.

For the upcoming 12 months, dividends amounting to 0.97 USD are expected. This corresponds to a dividend yield of 0.92 %.

Zimmer Biomet Holdings is assigned to the 'Health' sector.

To receive the latest dividend of Zimmer Biomet Holdings from 10/31/2024 amounting to 0.24 USD, you needed to have the stock in your portfolio before the ex-date on 9/30/2024.

The last dividend was paid out on 10/31/2024.

In the year 2023, Zimmer Biomet Holdings distributed 0.96 USD as dividends.

The dividends of Zimmer Biomet Holdings are distributed in USD.